Plasmodium falciparum malaria

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:disease
gptkbp:affects	humans
gptkbp:annualDeaths	over 400,000
gptkbp:antibioticResistance	artemisinin resistance chloroquine resistance mefloquine resistance
gptkbp:causedBy	gptkb:Plasmodium_falciparum
gptkbp:complication	gptkb:hypoglycemia acute renal failure severe anemia pulmonary edema cerebral malaria
gptkbp:diagnosedBy	blood smear microscopy rapid diagnostic test
gptkbp:firstDescribed	1880
gptkbp:globalBurden	most deadly malaria species
https://www.w3.org/2000/01/rdf-schema#label	Plasmodium falciparum malaria
gptkbp:incubationPeriod	9-14 days
gptkbp:mortalityRate	high
gptkbp:mostVulnerablePopulation	pregnant women immunocompromised individuals children under 5
gptkbp:namedAfter	gptkb:Plasmodium_falciparum
gptkbp:numberOfCases	over 200 million
gptkbp:prevalence	gptkb:Oceania gptkb:South_America gptkb:Southeast_Asia gptkb:sub-Saharan_Africa
gptkbp:prevention	mosquito control indoor residual spraying insecticide-treated bed nets antimalarial prophylaxis
gptkbp:symptom	gptkb:anemia fever fatigue headache chills
gptkbp:transmittedBy	gptkb:Anopheles_mosquito
gptkbp:treatment	gptkb:atovaquone-proguanil gptkb:mefloquine quinine artemisinin-based combination therapy
gptkbp:vaccineAvailable	gptkb:RTS,S/AS01
gptkbp:vectorFor	gptkb:Anopheles_funestus gptkb:Anopheles_gambiae gptkb:Anopheles_stephensi
gptkbp:WHOClassification	severe malaria
gptkbp:bfsParent	gptkb:atovaquone-proguanil gptkb:artesunate
gptkbp:bfsLayer	6